Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up
Guardado en:
Autor principal: | Calvo A.,Mario |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Chilena de Infectología
2005
|
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182005000200014 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nucleoside/Nucleotide Analogues for the Treatment of Chronic Hepatitis B: A 3-Year Follow Up Study
por: Andri Sanityoso Sulaiman, et al.
Publicado: (2021) -
Hepatitis B vaccine antibody response and the risk of clinical AIDS or death.
por: Michael L Landrum, et al.
Publicado: (2012) -
Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
por: Sheikh Mohammad Fazle Akbar, et al.
Publicado: (2021) -
Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans
por: Gui-Ping Wen, et al.
Publicado: (2020) -
Level of hepatitis B virus protection of first year medicine and nursing students in Mbarara University
por: S. Wakibi, et al.
Publicado: (2016)